Literature DB >> 15301830

Sequence analysis of the PLEXIN-D1 gene in Möbius syndrome patients.

Bert van der Zwaag1, Harriette T F M Verzijl, Karin H Wichers, Daniel Beltran-Valero de Bernabe, Han G Brunner, Hans van Bokhoven, George W Padberg.   

Abstract

Möbius syndrome is a rare congenital disease characterized by the paralysis of the facial nerve, accompanied by impaired ocular abduction. We have performed an extensive mutation analysis on a recently identified positional candidate gene, PLEXIN-D1, for Möbius syndrome 2 mapping to chromosome 3q21-q22. Southern analysis of patients from the Möbius syndrome 2 family and 41 isolated Möbius syndrome patients did not reveal chromosomal abnormalities in the PLEXIN-D1 gene. Direct sequencing of deoxyribonucleic acid from familial patients, and single-strand conformational polymorphism analysis of PLEXIN-D1 in 41 isolated patients identified 18 nucleotide changes. Seventeen of these 18 changes could be dismissed as polymorphisms, as they did not co-segregate with the disease, or were present in a control group. A single nucleotide change identified in intron 29 of an isolated Möbius syndrome patient could not be identified in a control group. However, the position of this nucleotide change makes it highly unlikely that it could be causative for Möbius syndrome in this patient because it does not affect known splicing sequences. Likewise, reverse transcriptase polymerase chain reaction analysis in patients from the Möbius syndrome 2 family did not reveal splicing aberrations, and revealed bi-allelic expression, ruling out the possibility of promoter disrupting mutations. Taken together, these results lead to the exclusion of the PLEXIN-D1 gene as the causative gene in Möbius syndrome 2, and in isolated Möbius syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15301830     DOI: 10.1016/j.pediatrneurol.2004.02.004

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  4 in total

Review 1.  Examining the genetics of congenital facial paralysis--a closer look at Moebius syndrome.

Authors:  Sameep Kadakia; Samuel N Helman; Thomas Schwedhelm; Masoud Saman; Babak Azizzadeh
Journal:  Oral Maxillofac Surg       Date:  2015-02-10

2.  Multigenic truncation of the semaphorin-plexin pathway by a germline chromothriptic rearrangement associated with Moebius syndrome.

Authors:  Lusine Nazaryan-Petersen; Inês R Oliveira; Mana M Mehrjouy; Juan M M Mendez; Mads Bak; Merete Bugge; Vera M Kalscheuer; Iben Bache; Dustin C Hancks; Niels Tommerup
Journal:  Hum Mutat       Date:  2019-05-14       Impact factor: 4.878

3.  Moebius syndrome: Craniofacial clinical manifestations and their association with prenatal exposure to misoprostol.

Authors:  Néstor O Ruge-Peña; Claudia Valencia; Dagoberto Cabrera; Daniel C Aguirre; Francisco Lopera
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-08-03

4.  De novo mutations in PLXND1 and REV3L cause Möbius syndrome.

Authors:  Laura Tomas-Roca; Anastasia Tsaalbi-Shtylik; Jacob G Jansen; Manvendra K Singh; Jonathan A Epstein; Umut Altunoglu; Harriette Verzijl; Laura Soria; Ellen van Beusekom; Tony Roscioli; Zafar Iqbal; Christian Gilissen; Alexander Hoischen; Arjan P M de Brouwer; Corrie Erasmus; Dirk Schubert; Han Brunner; Antonio Pérez Aytés; Faustino Marin; Pilar Aroca; Hülya Kayserili; Arturo Carta; Niels de Wind; George W Padberg; Hans van Bokhoven
Journal:  Nat Commun       Date:  2015-06-12       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.